Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children

ClinicalTrials.gov ID: NCT00383123

Public ClinicalTrials.gov record NCT00383123. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Single-blind, Randomized Study to Evaluate the Immunogenicity and Safety of Fluarix® (GSK Biologicals') Compared With Fluzone® (Aventis Pasteur/Sanofi) Administered Intramuscularly in Children (6 Months and Older)

Study identification

NCT ID
NCT00383123
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
3,327 participants

Conditions and interventions

Conditions

Interventions

  • Fluarix™ Biological
  • Fluzone Biological

Biological

Eligibility (public fields only)

Age range
6 Months to 17 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 1, 2006
Primary completion
Sep 30, 2007
Completion
Oct 18, 2007
Last update posted
Jun 7, 2018

2006 – 2007

United States locations

U.S. sites
40
U.S. states
13
U.S. cities
38
Facility City State ZIP Site status
GSK Investigational Site Antioch California 94509
GSK Investigational Site Fairfield California 94533
GSK Investigational Site Fresno California 93710
GSK Investigational Site Pleasanton California 94588
GSK Investigational Site Redwood City California 94063
GSK Investigational Site Richmond California 94801
GSK Investigational Site Rolling Hills Estates California 90274
GSK Investigational Site Sacramento California 95815
GSK Investigational Site San Francisco California 94102
GSK Investigational Site San Francisco California 94115
GSK Investigational Site Santa Clara California 95051
GSK Investigational Site Santa Rosa California 95403
GSK Investigational Site Vacaville California 95688
GSK Investigational Site Vallejo California 94589
GSK Investigational Site Walnut Creek California 94596
GSK Investigational Site Englewood Colorado 80112
GSK Investigational Site Lakewood Colorado 80401
GSK Investigational Site Tifton Georgia 31794
GSK Investigational Site Bardstown Kentucky 40004
GSK Investigational Site Lexington Kentucky 40509
GSK Investigational Site Metairie Louisiana 70006
GSK Investigational Site Omaha Nebraska 68134
GSK Investigational Site Whitehouse Station New Jersey 08889
GSK Investigational Site Fishkill New York 12524
GSK Investigational Site Hopewell Junction New York 12533
GSK Investigational Site Poughkeepsie New York 12603
GSK Investigational Site Rochester New York 14609
GSK Investigational Site Rochester New York 14620
GSK Investigational Site Cary North Carolina 27518
GSK Investigational Site Sylva North Carolina 28779
GSK Investigational Site Cleveland Ohio 44118
GSK Investigational Site Pittsburgh Pennsylvania 15241
GSK Investigational Site Uniontown Pennsylvania 15401
GSK Investigational Site Austin Texas 78728
GSK Investigational Site Fort Worth Texas 76135
GSK Investigational Site San Angelo Texas 76904
GSK Investigational Site Layton Utah 84041
GSK Investigational Site Salt Lake City Utah 84121
GSK Investigational Site South Jordan Utah 84095
GSK Investigational Site West Jordan Utah 84084

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00383123, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 7, 2018 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00383123 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →